The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic study of aging

Rosebud O Roberts, Yonas Endale Geda, David S Knopman, R. H. Cha, V. S. Pankratz, Bradley F Boeve, Eric George Tangalos, R. J. Ivnik, Walter A Rocca, Ronald Carl Petersen

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Objective: Although incidence rates for mild cognitive impairment (MCI) have been reported, few studies were specifically designed to measure the incidence of MCI and its subtypes using published criteria. We estimated the incidence of amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in men and women separately. Methods: A population-based prospective cohort of Olmsted County, MN, residents ages 70-89 years on October 1, 2004, underwent baseline and 15-month interval evaluations that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological testing. A panel of examiners blinded to previous diagnoses reviewed data at each serial evaluation to assess cognitive status according to published criteria. Results: Among 1,450 subjects who were cognitively normal at baseline, 296 developed MCI. The age-and sex-standardized incidence rate of MCI was 63.6 (per 1,000 person-years) overall, and was higher in men (72.4) than women (57.3) and for aMCI (37.7) than naMCI (14.7). The incidence rate of aMCI was higher for men (43.9) than women (33.3), and for subjects with ≤12 years of education (42.6) than higher education (32.5). The risk of naMCI was also higher for men (20.0) than women (10.9) and for subjects with ≤12 years of education (20.3) than higher education (10.2). Conclusions: The incidence rates for MCI are substantial. Differences in incidence rates by clinical subtype and by sex suggest that risk factors for MCI should be investigated separately for aMCI and naMCI, and in men and women.

Original languageEnglish (US)
Pages (from-to)342-351
Number of pages10
JournalNeurology
Volume78
Issue number5
DOIs
StatePublished - Jan 31 2012

Fingerprint

Incidence
Education
Cognitive Dysfunction
Clinic
Mild Cognitive Impairment
Nervous System
Dementia
Population
Evaluation

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

The incidence of MCI differs by subtype and is higher in men : The Mayo Clinic study of aging. / Roberts, Rosebud O; Geda, Yonas Endale; Knopman, David S; Cha, R. H.; Pankratz, V. S.; Boeve, Bradley F; Tangalos, Eric George; Ivnik, R. J.; Rocca, Walter A; Petersen, Ronald Carl.

In: Neurology, Vol. 78, No. 5, 31.01.2012, p. 342-351.

Research output: Contribution to journalArticle

@article{3b1724aa0b1c4ff587947774c6abf171,
title = "The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic study of aging",
abstract = "Objective: Although incidence rates for mild cognitive impairment (MCI) have been reported, few studies were specifically designed to measure the incidence of MCI and its subtypes using published criteria. We estimated the incidence of amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in men and women separately. Methods: A population-based prospective cohort of Olmsted County, MN, residents ages 70-89 years on October 1, 2004, underwent baseline and 15-month interval evaluations that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological testing. A panel of examiners blinded to previous diagnoses reviewed data at each serial evaluation to assess cognitive status according to published criteria. Results: Among 1,450 subjects who were cognitively normal at baseline, 296 developed MCI. The age-and sex-standardized incidence rate of MCI was 63.6 (per 1,000 person-years) overall, and was higher in men (72.4) than women (57.3) and for aMCI (37.7) than naMCI (14.7). The incidence rate of aMCI was higher for men (43.9) than women (33.3), and for subjects with ≤12 years of education (42.6) than higher education (32.5). The risk of naMCI was also higher for men (20.0) than women (10.9) and for subjects with ≤12 years of education (20.3) than higher education (10.2). Conclusions: The incidence rates for MCI are substantial. Differences in incidence rates by clinical subtype and by sex suggest that risk factors for MCI should be investigated separately for aMCI and naMCI, and in men and women.",
author = "Roberts, {Rosebud O} and Geda, {Yonas Endale} and Knopman, {David S} and Cha, {R. H.} and Pankratz, {V. S.} and Boeve, {Bradley F} and Tangalos, {Eric George} and Ivnik, {R. J.} and Rocca, {Walter A} and Petersen, {Ronald Carl}",
year = "2012",
month = "1",
day = "31",
doi = "10.1212/WNL.0b013e3182452862",
language = "English (US)",
volume = "78",
pages = "342--351",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The incidence of MCI differs by subtype and is higher in men

T2 - The Mayo Clinic study of aging

AU - Roberts, Rosebud O

AU - Geda, Yonas Endale

AU - Knopman, David S

AU - Cha, R. H.

AU - Pankratz, V. S.

AU - Boeve, Bradley F

AU - Tangalos, Eric George

AU - Ivnik, R. J.

AU - Rocca, Walter A

AU - Petersen, Ronald Carl

PY - 2012/1/31

Y1 - 2012/1/31

N2 - Objective: Although incidence rates for mild cognitive impairment (MCI) have been reported, few studies were specifically designed to measure the incidence of MCI and its subtypes using published criteria. We estimated the incidence of amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in men and women separately. Methods: A population-based prospective cohort of Olmsted County, MN, residents ages 70-89 years on October 1, 2004, underwent baseline and 15-month interval evaluations that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological testing. A panel of examiners blinded to previous diagnoses reviewed data at each serial evaluation to assess cognitive status according to published criteria. Results: Among 1,450 subjects who were cognitively normal at baseline, 296 developed MCI. The age-and sex-standardized incidence rate of MCI was 63.6 (per 1,000 person-years) overall, and was higher in men (72.4) than women (57.3) and for aMCI (37.7) than naMCI (14.7). The incidence rate of aMCI was higher for men (43.9) than women (33.3), and for subjects with ≤12 years of education (42.6) than higher education (32.5). The risk of naMCI was also higher for men (20.0) than women (10.9) and for subjects with ≤12 years of education (20.3) than higher education (10.2). Conclusions: The incidence rates for MCI are substantial. Differences in incidence rates by clinical subtype and by sex suggest that risk factors for MCI should be investigated separately for aMCI and naMCI, and in men and women.

AB - Objective: Although incidence rates for mild cognitive impairment (MCI) have been reported, few studies were specifically designed to measure the incidence of MCI and its subtypes using published criteria. We estimated the incidence of amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in men and women separately. Methods: A population-based prospective cohort of Olmsted County, MN, residents ages 70-89 years on October 1, 2004, underwent baseline and 15-month interval evaluations that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological testing. A panel of examiners blinded to previous diagnoses reviewed data at each serial evaluation to assess cognitive status according to published criteria. Results: Among 1,450 subjects who were cognitively normal at baseline, 296 developed MCI. The age-and sex-standardized incidence rate of MCI was 63.6 (per 1,000 person-years) overall, and was higher in men (72.4) than women (57.3) and for aMCI (37.7) than naMCI (14.7). The incidence rate of aMCI was higher for men (43.9) than women (33.3), and for subjects with ≤12 years of education (42.6) than higher education (32.5). The risk of naMCI was also higher for men (20.0) than women (10.9) and for subjects with ≤12 years of education (20.3) than higher education (10.2). Conclusions: The incidence rates for MCI are substantial. Differences in incidence rates by clinical subtype and by sex suggest that risk factors for MCI should be investigated separately for aMCI and naMCI, and in men and women.

UR - http://www.scopus.com/inward/record.url?scp=84858019144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858019144&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3182452862

DO - 10.1212/WNL.0b013e3182452862

M3 - Article

C2 - 22282647

AN - SCOPUS:84858019144

VL - 78

SP - 342

EP - 351

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 5

ER -